Blonder Tongue Laboratories Yönetim

Yönetim kriter kontrolleri 1/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Bob Palle

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	1.7yrs
CEO sahipliği	16.8%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	14.2yrs

Son yönetim güncellemeleri

Recent updates

Have Blonder Tongue Laboratories, Inc. (NYSEMKT:BDR) Insiders Been Selling Their Stock?

Dec 23

CEO Tazminat Analizi

Bob Palle'un ücretlendirmesi Blonder Tongue Laboratories'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Dec 31 2022	US$27k	n/a	-US$3m
Sep 30 2022	n/a	n/a	-US$4m
Jun 30 2022	n/a	n/a	-US$3m
Mar 31 2022	n/a	n/a	-US$656k
Dec 31 2021	US$38k	n/a	US$84k
Sep 30 2021	n/a	n/a	-US$1m
Jun 30 2021	n/a	n/a	-US$3m
Mar 31 2021	n/a	n/a	-US$6m
Dec 31 2020	n/a	n/a	-US$7m
Sep 30 2020	n/a	n/a	-US$9m
Jun 30 2020	n/a	n/a	-US$8m
Mar 31 2020	n/a	n/a	-US$8m
Dec 31 2019	US$534k	US$491k	-US$742k
Sep 30 2019	n/a	n/a	US$2m
Jun 30 2019	n/a	n/a	US$3m
Mar 31 2019	n/a	n/a	US$4m
Dec 31 2018	US$170k	US$60k	-US$1m
Sep 30 2018	n/a	n/a	-US$341k
Jun 30 2018	n/a	n/a	-US$295k
Mar 31 2018	n/a	n/a	-US$191k
Dec 31 2017	US$161k	US$42k	-US$384k

Tazminat ve Piyasa: Insufficient data to establish whether Bob's total compensation is reasonable compared to companies of similar size in the US market.

Tazminat ve Kazançlar: Insufficient data to compare Bob's compensation with company performance.

CEO

Bob Palle (78 yo)

1.7yrs

Görev süresi

US$26,542

Tazminat

Mr. Robert J. Palle, Jr., also known as Bob, has been the Chief Executive Officer and President at Blonder Tongue Laboratories, Inc. since March 17, 2023. Mr. Palle serves as Director of Blonder Tongue Lab...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Robert Palle	CEO, President & Director	31.2yrs	US$26.54k	16.84% $ 244.5k
Gary Scharmett	Independent Director	26.9yrs	US$26.54k	1.99% $ 28.9k
James Williams	Independent Director	31.2yrs	US$26.54k	1.61% $ 23.4k
Stephen Necessary	Independent Director	6.8yrs	US$26.54k	1.34% $ 19.5k
Steven Shea	Independent Chairman	15.2yrs	US$26.54k	4.51% $ 65.5k
Charles Dietz	Independent Director	13.2yrs	US$26.54k	2.02% $ 29.4k
John Burke	Independent Director	4.8yrs	US$26.54k	0.027% $ 388.6
Michael Hawkey	Independent Director	4.4yrs	US$26.54k	0.076% $ 1.1k

14.2yrs

Ortalama Görev Süresi

66.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: BDRL's board of directors are seasoned and experienced ( 14.2 years average tenure).

Blonder Tongue Laboratories Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Blonder Tongue Laboratories, Inc. Announces the Retirement of Stephen K. Necessary from the Board

Blonder Tongue Laboratories, Inc. Announces President Changes

Blonder Tongue Laboratories, Inc. Announces Furloughing Ronald V. Alterio, the Senior Vice President-Engineering and Chief Technology Officer

Blonder Tongue Laboratories, Inc. Announces Resignation of Anthony Bruno as BOD, Effective from May 25, 2022

Blonder Tongue Laboratories, Inc., Annual General Meeting, May 25, 2022

Blonder Tongue Laboratories, Inc. Announces Retirement of James H. Williams as Member of the Board of Director

Recent updates

Blonder Tongue Announces IP Failover Feature Added to NXG Video Delivery System

Blonder Tongue Laboratories, Inc. Announces the Retirement of Stephen K. Necessary from the Board

Blonder Tongue Laboratories, Inc. Announces President Changes

Blonder Tongue Laboratories, Inc. to Report Q3, 2022 Results on Nov 04, 2022

Blonder Tongue Laboratories Announces Product Standardization with Tier One Broadband Cable Operator

Blonder Tongue Laboratories, Inc. to Report Q2, 2022 Results on Aug 15, 2022

Blonder Tongue Laboratories, Inc.(OTCPK:BDRL) dropped from S&P TMI Index

NYSE American to Suspend Trading Immediately in Blonder Tongue Laboratories

Blonder Tongue Laboratories, Inc. Announces Furloughing Ronald V. Alterio, the Senior Vice President-Engineering and Chief Technology Officer

Blonder Tongue Laboratories, Inc. Announces Resignation of Anthony Bruno as BOD, Effective from May 25, 2022

Blonder Tongue Laboratories, Inc., Annual General Meeting, May 25, 2022

Blonder Tongue Laboratories, Inc. Announces Retirement of James H. Williams as Member of the Board of Director

NYSE American to Commence Delisting Proceedings Against Blonder Tongue Laboratories

Independent Director Rick Briggs has left the company

Independent Director recently sold US$102k worth of stock

Third quarter 2021 earnings released: US$0.016 loss per share (vs US$0.18 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS US$0.14 (vs US$0.12 loss in 2Q 2020)

Director recently sold US$74k worth of stock

First quarter 2021 earnings released: US$0.036 loss per share (vs US$0.21 loss in 1Q 2020)

Full year 2020 earnings released: US$0.76 loss per share (vs US$0.077 loss in FY 2019)

Independent Director recently sold US$77k worth of stock

Blonder Tongue Laboratories, Inc. announced that it has received $0.6 million in funding

New 90-day high: US$1.85

MD of Strategic Accounts & Director recently sold US$52k worth of stock

Have Blonder Tongue Laboratories, Inc. (NYSEMKT:BDR) Insiders Been Selling Their Stock?

Blonder Tongue Laboratories Receives Non-Compliance Letter from NYSE American

New 90-day high: US$1.75

Third quarter 2020 earnings released: US$0.18 loss per share

New 90-day high: US$1.50

NYSE Accepts Compliance Plan of Blonder Tongue Laboratories, Inc

New 90-day high - US$1.35

Earnings released

Blonder Tongue Laboratories, Inc. to Report Q2, 2020 Results on Aug 07, 2020